Berberine Protects against High-Energy and Low-Protein Diet-Induced Hepatic Steatosis: Modulation of Gut Microbiota and Bile Acid Metabolism in Laying Hens

Int J Mol Sci. 2023 Dec 9;24(24):17304. doi: 10.3390/ijms242417304.

Abstract

Berberine (BBR) is a natural alkaloid with multiple biotical effects that has potential as a treatment for fatty liver hemorrhagic syndrome (FLHS). However, the mechanism underlying the protective effect of BBR against FLHS remains unclear. The present study aimed to investigate the effect of BBR on FLHS induced by a high-energy, low-protein (HELP) diet and explore the involvement of the gut microbiota and bile acid metabolism in the protective effects. A total of 90 healthy 140-day-old Hy-line laying hens were randomly divided into three groups, including a control group (fed a basic diet), a HELP group (fed a HELP diet), and a HELP+BBR group (high-energy, high-protein diet supplemented with BBR instead of maize). Our results show that BBR supplementation alleviated liver injury and hepatic steatosis in laying hens. Moreover, BBR supplementation could significantly regulate the gut's microbial composition, increasing the abundance of Actinobacteria and Romboutsia. In addition, the BBR supplement altered the profile of bile acid. Furthermore, the gut microbiota participates in bile acid metabolism, especially taurochenodeoxycholic acid and α-muricholic acid. BBR supplementation could regulate the expression of genes and proteins related to glucose metabolism, lipid synthesis (FAS, SREBP-1c), and bile acid synthesis (FXR, CYP27a1). Collectively, our findings demonstrate that BBR might be a potential feed additive for preventing FLHS by regulating the gut microbiota and bile acid metabolism.

Keywords: berberine; bile acids; fatty liver hemorrhagic syndrome; gut microbiota; high-energy and low-protein diet.

MeSH terms

  • Animals
  • Berberine* / metabolism
  • Berberine* / pharmacology
  • Berberine* / therapeutic use
  • Bile Acids and Salts / metabolism
  • Chickens
  • Diet, Protein-Restricted
  • Fatty Liver* / drug therapy
  • Fatty Liver* / etiology
  • Fatty Liver* / prevention & control
  • Female
  • Gastrointestinal Microbiome*
  • Liver / metabolism

Substances

  • Berberine
  • Bile Acids and Salts

Supplementary concepts

  • Floating-harbor syndrome